REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,372.00
Bid: 12,370.00
Ask: 12,374.00
Change: 40.00 (0.32%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Spain limits AstraZeneca coronavirus vaccine to over 60-year olds

Wed, 07th Apr 2021 23:14

(Recasts to focus on AstraZeneca)

MADRID, April 7 (Reuters) - Spain will only give
AstraZeneca's coronavirus vaccine to people over 60 years old
after European and British regulators found a potential link
between the shot and rare brain blood clots.

"The vaccination strategy is changing and from tomorrow only
over 60-year-olds will be vaccinated with AstraZeneca," Health
Minister Carolina Darias told a news conference late on
Wednesday following a meeting of regional health chiefs.

Darias said a decision would be taken on Thursday on whether
to administer the second round of the vaccine to people who had
already received their first dose.

The European Medicines Agency announced earlier it had
reports of 169 cases of the rare clotting disorder out of 34
million doses administered within Europe, roughly one for every
100,000 people under 60 vaccinated. Most occurred in women under
60 and within two weeks of injection. [nL1N2M01J1

Maria Jesus Lamas, director of Spain's drug regulator, said
that number was higher than expected, though very small:
"Despite the rarity of these side effects, the modification to
the technical guidance is important," Lamas said.

A summit of European Union health ministers failed to agree
on common guidance for the vaccine and the EMA said countries
should set their own regulations.

Spain's decision follows Italy recommending the shot only
for those over 60 and Britain said people under 30 should get an
alternative.

People lining up for a shot in Madrid earlier on Wednesday
vented frustration at constantly changing guidance for the
vaccine, which is subject to a patchwork of different rules
governing its use.

"Today has been a very distressing day because of all the
news coming from the European Medicines Agency," said Carmen
Ruiz after coming out of Atletico Madrid's Wanda football
stadium, now converted into a vaccine centre.

Though Spain is faring better than neighbouring France,
where rampant infections have pushed hospital admittance rates
to near five-month highs, the daily caseload has been increasing
for three weeks.

The health ministry registered 8,788 new cases, bringing the
total to 3.33 million. The death toll rose by 126 to 76,037.

Wary that increased social contact over Easter could trigger
a full-blown fourth wave, authorities in Catalonia, the Basque
Country and Aragon imposed fresh restrictions on movement.

(Reporting by Clara-Laeila Laudette, Guillermo Martinez, Elena
Rodriguez, Nathan Allen and Joan Faus, editing by Andrei Khalip
and Grant McCool)

More News
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.